Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,293JPY
16 Nov 2018
Change (% chg)

¥-114 (-2.59%)
Prev Close
¥4,407
Open
¥4,357
Day's High
¥4,365
Day's Low
¥4,285
Volume
7,734,500
Avg. Vol
4,781,169
52-wk High
¥6,693
52-wk Low
¥4,203

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -71.44 March 17 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 5 5 4 3
(3) HOLD 1 1 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.70 1.70 1.80 1.78

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 410,578.00 411,156.00 410,000.00 --
Year Ending Mar-18 11 1,771,210.00 1,809,940.00 1,723,500.00 --
Year Ending Mar-19 7 1,762,630.00 1,790,000.00 1,737,000.00 1,756,950.00
Year Ending Mar-20 6 1,811,560.00 1,877,340.00 1,771,000.00 1,818,900.00
Earnings (per share)
Quarter Ending Mar-18 2 -71.44 -60.20 -82.68 --
Year Ending Mar-18 11 216.49 248.40 200.50 --
Year Ending Mar-19 7 199.94 276.06 134.48 187.77
Year Ending Mar-20 6 233.38 312.90 204.70 214.58
LT Growth Rate (%) 3 7.87 15.29 -1.98 6.89

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 432,000.00 449,834.00 17,834.00 4.13
Quarter Ending Mar-18 410,578.00 400,963.00 9,615.00 2.34
Quarter Ending Dec-17 447,897.00 488,152.00 40,255.34 8.99
Quarter Ending Sep-17 438,894.00 433,176.00 5,718.00 1.30
Quarter Ending Jun-17 419,498.00 448,240.00 28,742.50 6.85

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 410,578.00 -- -- -- --
Year Ending Mar-18 1,771,210.00 -- -- -- --
Year Ending Mar-19 1,762,630.00 1,764,430.00 1,765,050.00 1,766,350.00 1,756,950.00
Year Ending Mar-20 1,811,560.00 1,814,150.00 1,817,130.00 1,817,790.00 1,818,900.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 -- -- -- --
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 1 1 1 1
Year Ending Mar-20 0 1 0 1
Earnings